Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia

Neurobiology of Aging

Volumn 30, Issue 2, 2009, Pages 266-271

  Helbecque, Nicole ^a   Cottel, Dominique ^a   Amouyel, Philippe ^a,b  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Alzheimer's disease; Genetic association study; Genetic polymorphism; Low density lipoprotein; LRP8

Indexed keywords

APOLIPOPROTEIN E; ARGININE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 8; NUCLEAR PROTEIN; PROTEIN JIP 1; PROTEIN MAPK8IP1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

AGED; ALZHEIMER DISEASE; COMORBIDITY; DEMENTIA; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTORS, LIPOPROTEIN; RISK ASSESSMENT; RISK FACTORS;

EID: 57849100587     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.05.024     Document Type: Article

References (20)

1. Amouyel P., Richard F., Cottel D., Amant C., Codron V., and Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217 (1996) 203-205
2. Beffert U., Morfini G., Bock H.H., Reyna H., Brady S.T., and Herz J. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J. Biol. Chem. 277 (2002) 49958-49964
3. Beffert U., Weeber E.J., Durudas A., Qiu S., Masiulis I., Sweatt J.D., Li W.P., Adelmann G., Frotscher M., Hammer R.E., and Herz J. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47 (2005) 567-579
4. Bonny C., Oberson A., Steinmann M., Schorderet D.F., Nicod P., and Waeber G. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J. Biol. Chem. 275 (2000) 16466-16472
5. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., and Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 27 (2007) 2727-2733
6. D'Ambrosio C., Arena S., Fulcoli G., Scheinfeld M.H., Zhou D., D'Adamio L., and Scaloni A. Hyperphosphorylation of JNK-interacting Protein 1, a protein associated with Alzheimer Disease. Mol. Cell Proteomics 5 (2006) 97-113
7. Helbecque N., Abderrhamani A., Meylan L., Riederer B., Mooser V., Miklossy J., Delplanque J., Boutin P., Nicod P., Haefliger J.A., Cottel D., Amouyel P., Froguel P., and Waeber G. Islet-brain1/c-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease. Mol. Psychiatry 8 (2003) 413-422
8. Hoe H.S., Pocivavsek A., Chakraborty G., Fu Z., Vicini S., Ehlers M.D., and Rebeck G.W. Apolipoprotein E receptor 2 interactions with the N-methyl-d-aspartate receptor. J. Biol. Chem. 281 (2006) 3425-3431
9. Kehoe P., Wavrant-De V.F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M.C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J., and Owen M.J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8 (1999) 237-245
10. Ma S.L., Ng H.K., Baum L., Pang J.C., Chiu H.F., Woo J., Tang N.L., and Lam L.C. Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease. Neurosci. Lett. 332 (2002) 216-218
11. Matsuda S., Matsuda Y., and D'Adamio L. Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J. Biol. Chem. 278 (2003) 38601-38606
12. May P., Herz J., and Bock H.H. Molecular mechanisms of lipoprotein receptor signalling. Cell Mol. Life Sci. 62 (2005) 2325-2338
13. Munoz V., and Serrano L. Elucidating the folding problem of helical peptides using empirical parameters. II. Helix macrodipole effects and rational modification of the helical content of natural peptides. J. Mol. Biol. 245 (1995) 275-296
14. 2-terminal kinase-interacting protein-1. J. Cell Biol. 171 (2005) 615-625
15. Petit-Turcotte C., Aumont N., Beffert U., Dea D., Herz J., and Poirier J. The apoE receptor apoER2 is involved in the maintenance of efficient synaptic plasticity. Neurobiol. Aging 26 (2005) 195-206
16. Saez-Valero J., Costell M., Sjogren M., Andreasen N., Blennow K., and Luque J.M. Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J. Neurosci. Res. 72 (2003) 132-136
17. Stockinger W., Brandes C., Fasching D., Hermann M., Gotthardt M., Herz J., Schneider W.J., and Nimpf J. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J. Biol. Chem. 275 (2000) 25625-25632
18. Stokin G.B., and Goldstein L.S. Linking molecular motors to Alzheimer's disease. J. Physiol. Paris 99 (2006) 193-200
19. Taru H., Kirino Y., and Suzuki T. Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J. Biol. Chem. 277 (2002) 27567-27574
20. Verhey K.J., Meyer D., Deehan R., Blenis J., Schnapp B.J., Rapoport T.A., and Margolis B. Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J. Cell Biol. 152 (2001) 959-970